09:33 EST BioMarin jumps 8% to $82.58 after Reuters report of Elliott stake
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BMRN:
- BioMarin (NASDAQ:BMRN) Gains after Elliott Investment Picks Up Stake
- BioMarin price target lowered to $91 from $104 at Canaccord
- BioMarin price target lowered to $115 from $125 at Piper Sandler
- BioMarin price target lowered to $111 from $125 at Barclays
- BioMarin names Alexander Hardy CEO, succeeding Jean-Jacques Bienaime